NextCure  Inc (NXTC) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $13.00
• Market Cap: $45.71M
• EPS: $-23.81
• 52-Week High: $15.74
• 52-Week Low: $2.69

About NextCure  Inc

NextCure, Inc. (NXTC) is a clinical-stage biopharmaceutical firm located in Beltsville, Maryland, dedicated to pioneering immunomedicines for cancer and various immune-related disorders. Utilizing its advanced NEX-T technology platform, the company aims to restore and optimize immune function, thereby developing innovative treatment options for patients with significant therapeutic gaps. With a robust pipeline and a commitment to addressing pressing healthcare challenges, NextCure is strategi...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for NextCure  Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does NXTC pay dividends?

NextCure  Inc (NXTC) does not currently pay a regular dividend.

What is NXTC's market cap?

NextCure  Inc (NXTC) has a market capitalization of $45.71M with a current stock price of $13.00.